Sabyasachy Mistry | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Sabyasachy Mistry | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Sabyasachy Mistry , US FDA , United States

Sabyasachy (Babu) Mistry is a highly skilled bioanalyst with over sixteen years of experience in analytical chemistry, organic synthesis, and bioanalytical method development. He is currently working at the US Food and Drug Administration (FDA) in Silver Spring, MD. Mistry has a broad expertise that spans liquid chromatography-mass spectrometry (LC-MS/MS), enzyme-linked immunosorbent assay (ELISA), nuclear magnetic resonance (NMR), and various organic chemistry techniques. With strong communication and problem-solving skills, Mistry excels both as a team member and independent researcher. He has contributed to multiple scientific publications, focusing on pharmacokinetics, drug discovery, and regulatory practices, in addition to mentoring students and offering leadership roles in academic settings.

Publication Profile: 

Scopus

Strengths for the Award:

Sabyasachy (Babu) Mistry’s distinguished experience in analytical and bioanalytical chemistry makes him a strong contender for the Research for Best Researcher Award. With over sixteen years of experience, his expertise spans liquid chromatography-mass spectrometry (LC-MS/MS), enzyme-linked immunosorbent assays (ELISA), and computational chemistry, among others. His work in drug solubility and pharmacokinetics, particularly his contributions to hERG assays, is highly relevant to regulatory sciences. Mistry’s capacity to bridge scientific inquiry with FDA regulations ensures his research not only advances scientific understanding but also directly supports regulatory science. His well-documented research, combined with leadership roles and multiple awards, reinforces his research excellence.

Areas for Improvements:


While Mistry’s expertise is extensive, further expansion into collaborative, cross-disciplinary projects could further enrich his body of work. Engaging more in international research initiatives could lead to innovative research outcomes and foster broader scientific networks.

Education:

Sabyasachy Mistry holds a Ph.D. in Analytical Chemistry from Purdue University, where he conducted research under the guidance of Professor Paul G. Wenthold. His dissertation focused on mass spectrometric detection of indophenols for phenol analysis. Prior to this, Mistry completed his M.S. in Organic Chemistry from the University of Dhaka in Bangladesh, where he worked with Professor Nilufar Nahar. His solid educational foundation, combined with his hands-on research experience, has provided him with expertise in a wide range of scientific disciplines, including analytical chemistry, organic synthesis, and bioanalytical methods. Furthermore, Mistry completed the CERSI Immersion Course in Drug Discovery, Drug Development, and Regulation at the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation, strengthening his knowledge in FDA regulations and drug development processes.

Experience:

Mistry’s extensive professional experience spans over a decade in both academic and regulatory environments. Since 2020, he has been serving as a Bio-analyst at the US Food and Drug Administration (FDA), where he applies his expertise in analytical chemistry to support drug discovery and regulatory science. At Purdue University, Mistry worked as a Teaching Assistant (TA) and Head TA in the Department of Chemistry from 2014 to 2020, fostering the growth of new scientists while also contributing to research. His responsibilities included conducting experiments, guiding graduate students, and presenting research findings. Mistry’s work involves advanced techniques such as LC-MS/MS, HPLC, NMR, and computational chemistry tools like Gaussian and Q-Chem. His cross-disciplinary research has contributed to the scientific understanding of pharmacokinetics, drug solubility, and enzyme activity, aligning with regulatory practices in drug approval processes.

Awards and Honors:

Sabyasachy Mistry has been recognized for his outstanding contributions to analytical and bioanalytical chemistry. He was awarded the Graduate Student Travel Award at the 67th ASMS Conference on Mass Spectrometry and Allied Topics in June 2019 in Atlanta, GA. Additionally, Mistry received multiple Travel Scholarships for his student work at the ASMS conferences from 2016 to 2018, showcasing his dedication to advancing scientific knowledge. His role as a volunteer and mentor further exemplifies his leadership within the academic community. These awards highlight his exceptional skills in mass spectrometry and analytical techniques, further solidifying his expertise in the field of chemical research. Mistry’s ability to present complex scientific data and his contributions to regulatory science have garnered recognition from peers and industry professionals alike.

Research Focus:

Sabyasachy Mistry’s research focuses on bioanalytical chemistry, pharmacokinetics, and regulatory science, particularly in drug discovery and development. His work involves the application of advanced techniques such as LC-MS/MS, ELISA, HPLC, and mass spectrometry to investigate drug interactions, solubility, and bioavailability. Mistry’s research also extends to the computational aspects of chemistry, using density functional theory (DFT) calculations to predict reaction profiles and optimize molecular interactions. A key area of interest for Mistry is studying the effects of drug formulations on biological systems, particularly through hERG assays to assess drug safety and efficacy. His work aligns with FDA regulations and contributes to improving drug regulatory processes. Additionally, Mistry has a strong background in organic chemistry, working on the synthesis and modification of small organic molecules. This combination of experimental and computational chemistry makes his research multifaceted, bridging the gap between scientific discovery and regulatory implementation.

Publications Top Notes:

  1. Determination of Lopinavir and Ritonavir in hERG solution to Support In Vitro hERG Block Potency Assessment Using LC-MS/MS: The Challenge of Poor Drug Solubility 📑
  2. Evaluation of a Sequential Antibiotic Treatment Regimen of Ampicillin, Ciprofloxacin, and Fosfomycin against Escherichia coli CFT073 in the Hollow Fiber Infection Model Compared with Simultaneous Combination Treatment 💊
  3. Determination of Five Positive Control Drugs in hERG External Solution (Buffer) by LC-MS/MS to Support In Vitro hERG Assay as Recommended by ICH S7B ⚖️
  4. Probing the Pyrolysis of Guaiacol and Dimethoxybenzenes Using Collision-Induced Dissociation Charge-Remote Fragmentation Mass Spectrometry 🔬
  5. Investigation of the Substituent Effects of the Azide Functional Group Using the Gas-Phase Acidities of 3- and 4-Azidophenols 📚
  6. Mass Spectrometric Detection of the Gibbs Reaction for Phenol Analysis 🔍
  7. Participation of C-H Protons in the Dissociation of a Proton Deficient Dipeptide 💡
  8. The HIVToolbox 2 Web System Integrates Sequence, Structure, Function and Mutation Analysis 🧬
  9. The Geogenomic Mutational Atlas of Pathogens (GoMAP) Web System 🌍
  10. Effect of Sodium Bicarbonate on the Mechanical and Degradation Properties of Short Jute Fiber Reinforced Polypropylene Composite by Extrusion Technique 🔧

Conclusion:

Sabyasachy Mistry has demonstrated exceptional scientific acumen and practical contributions in the field of bioanalytical chemistry. His expertise and leadership in various research domains position him as an excellent candidate for the Research for Best Researcher Award. His continued work on drug discovery and regulatory science will likely result in even greater contributions to both the scientific and regulatory communities.

 

 

 

Felicia ANTOHE | Molecular Mechanisms Signaling | Molecular Cell Biology Award

Dr. Felicia ANTOHE | Molecular Mechanisms Signaling | Molecular Cell Biology Award

Dr. Felicia ANTOHE , Inst. Cellular Biology and Pathology NS , Romania

Dr. Felicia Antohe is the Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy. With a background in cellular biology and biophysics, she has contributed significantly to biomedical research, particularly in vascular endothelium, atherosclerosis, diabetes, and immune disorders. She has received multiple prestigious awards and conducted pioneering research, especially on the transcytosis of macromolecules in endothelial cells. As a PhD advisor, she mentors young researchers, having guided 12 PhD students to date. Dr. Antohe is an internationally recognized expert with extensive experience in immunology, cell biology, and proteomics.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Felicia Antohe stands out as an exceptional candidate for the Research for Molecular Cell Biology Award due to her extensive academic and research achievements. As Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy, her leadership in pioneering research in endothelial cell biology and vascular pathologies has been transformative. Dr. Antohe’s strong academic background, with a Master’s in Biophysics and a PhD in Cellular Biology, complements her robust research portfolio. With over 170 scientific papers, 90 of which are indexed in Web of Science, she is recognized for her contributions to molecular mechanisms in diseases such as atherosclerosis, diabetes, and immune disorders. Furthermore, her work on monoclonal antibodies and proteomics has had a significant impact on both scientific and clinical advancements.

Areas for Improvement:

While Dr. Antohe’s research is highly regarded, there is potential for greater integration of her research with cutting-edge technologies in bioinformatics and computational biology. This could further expand her work on proteomics and molecular mechanisms. Additionally, there is an opportunity for broader outreach to apply her findings in practical therapeutic contexts through collaborations with pharmaceutical companies or clinical trials. Expanding her influence in translational research could have a larger impact on public health, especially in diseases such as diabetes and cardiovascular disorders.

Education:

Dr. Felicia Antohe holds a Master’s degree in Biophysics from the University of Bucharest (1977). She completed her PhD in Cellular Biology at the Romanian Academy’s Institute of Cellular Biology and Pathology (1994). In addition to her formal education, she has been a PhD coordinator since 2000 and has contributed significantly to research training at national and international levels. Her work blends theoretical knowledge with cutting-edge lab techniques in molecular biology, proteomics, and immunology.

Experience:

Dr. Antohe’s research experience spans numerous roles. She is currently the Principal Investigator and Member of the Scientific Council at the Romanian Academy’s Institute of Cellular Biology and Pathology. She has also worked as a visiting scientist at prestigious institutions like McGill University, University of Alberta, and Max Planck Institute. She has coordinated over 44 research projects, including national and international grants, and is actively involved in multiple collaborative research efforts across Europe and beyond. Her leadership in cell biology and proteomics is widely recognized.

Awards and Honors:

Dr. Antohe has received numerous awards, including the EURESCO Prize (2001), the BIO-RAD Laboratories Prize for valuable research (2002), and the Romanian Academy Emil Racovita Prize (1991). She has also won multiple international recognitions for her scientific contributions, such as the Best Poster award at the “8th International Conference on Vascular Endothelium” (2005), and various fellowships and grants from organizations like COST and the European Science Foundation.

Research Focus:

Dr. Antohe’s research focuses on endothelial cell biology, particularly transcytosis, endocytosis, and cell receptor mechanisms in both health and disease. She investigates the bio-pathology of atherosclerosis, diabetes, and immune disorders, with particular attention to the transport of macromolecules across vascular cells. Her work also explores the role of monoclonal antibodies as diagnostic and therapeutic tools. She applies proteomic techniques to study endothelial cell function, aiming to understand vascular biology at molecular and cellular levels.

Publications Top Notes:

  • The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans 📄
  • Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice 📄
  • Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey 📄
  • Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells 📄
  • Analytical techniques for multiplex analysis of protein biomarkers 📄
  • Functional ultrastructure of the vascular endothelium: changes in various pathologies 📄
  • Effect of enoxaparin on high glucose-induced activation of endothelial cells 📄
  • Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells 📄
  • Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey 📄
  • Establishment of a pure vascular endothelial cell line from human placenta 📄

Conclusion:

Dr. Felicia Antohe is an outstanding researcher whose work has greatly advanced our understanding of endothelial cell biology, molecular transport, and disease mechanisms. Her combination of technical expertise, leadership in multiple high-impact research projects, and numerous prestigious awards positions her as an ideal candidate for the Research for Molecular Cell Biology Award. While there is always room to expand her research applications, her contributions to science are already substantial and impactful.